Synopsis: The Shares of this company rose nearly 6% after announcing Tricity expansion plans, with a strong capacity addition pipeline and improving operational metrics supporting the company’s growth outlook.
The shares of this company, which has a strong focus on expansion and launched a Rs. 920 crore IPO in December 2025 to fund further acquisitions and technological upgrades, came into focus after announcing the tricity expansion
With the market capitalization of Rs 9,122 crore, Park Medi World Ltd’s share on Friday made a day high of Rs 216 per share, up by 5.7 percent from its previous day’s close price of Rs 204.35. The share of the company has given a 36 percent return since its IPO in December 2025
What happened
Park Group of Hospitals has launched a multi-super specialty hospital in Panchkula while expanding its Mohali facility, strengthening its presence across the Tricity region. The move aims to improve access to advanced healthcare services across Haryana, Punjab, Himachal Pradesh, and Chandigarh.
Focus on Advanced Tertiary Care: The Panchkula hospital offers high-end medical services, including oncology, cardiology, neurosciences, and orthopaedics, supported by advanced diagnostics and critical care infrastructure. With capabilities like robotic-assisted procedures, it is designed to reduce reliance on metro cities such as Delhi for complex treatments.
Park Hospitals’ leadership said the Panchkula launch and Mohali expansion will build a large integrated network with around 850 beds in Tricity. The focus is on advanced care, strong clinical governance, modern infrastructure, and improving patient outcomes through technology and expertise.
Scale-Up Strategy Backed Capex and Operations Drive Growth
Growth Strategy: The company is driving growth through a mix of greenfield and brownfield expansions, with plans to launch a 360-bed hospital in Agra and a 300-bed facility in Panchkula. This will add 660 beds in FY26, taking total capacity to around 3,910 beds.
Further expansion includes 500 beds in FY27 across Kanpur and Delhi, followed by 850 beds in FY28 in Gorakhpur, Ambala, and Rohtak. This is expected to scale capacity to nearly 5,260 beds, while maintaining EBITDA margins of 27 percent and PAT margins of 17 percent.
Operational Performance and Growth Trends: The company has witnessed strong growth in patient volumes, with total footfall rising from 5.32 lakh last year to 6.6 lakh in the first nine months of the current year, marking a 24 percent increase. Bed capacity also expanded from 3,000 to 3,250, supported by the addition of a 250-bed facility.
Operational metrics remained stable, with ARPOB improving from Rs 25,500 to Rs 27,400, while ALOS moderated slightly to 6.34 days. Occupancy increased from 62 percent to 65 percent despite capacity additions, and capex per bed remained steady at around Rs 34 lakh.
Capex & Balance Sheet: The company plans to add 2,010 beds by March 2028, with projects in Panchkula starting operations in March 2026, followed by expansions in Kanpur and Delhi in FY27, and further additions in Gorakhpur, Ambala, and Rohtak in FY28. This expansion will be supported by a total capex of around Rs 700 crore, while maintaining a consistent per-bed cost of about Rs 35 lakh.
The company has significantly reduced its debt from Rs 425 crore pre-IPO, repaying around Rs 380 crore in recent months. As of January end, debt stands at about Rs 15 crore, which is expected to be fully repaid by February, making it a debt-free company.
About the Company
Park Medi World Ltd is a major private hospital chain in North India, operating multi-super speciality hospitals across Haryana, Delhi, Punjab, and Rajasthan. Founded with a focus on affordable care, it specializes in over 30 areas, including cardiology and oncology, and is expanding its regional footprint through organic growth and acquisitions.
Financial Highlights: The revenue from operations grew by 17.8 percent to Rs 410 crore in Q3 FY26, corresponding to the same quarter in the last financial year, and the financing margin stayed flat at 24 percent YoY. Accompanied by a net profit growth of 15.2 percent to Rs 53 crore in Q3 FY26 from Rs 46 crore in Q3 FY25, resulting in an EPS decline of 60.2 percent to Rs 1.18 per share in Q3 FY26.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
The post Healthcare Stock Jumps 6% on a ₹700 Cr Capex and 5,260 Bed Expansion Plan appeared first on Trade Brains.